FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3083232014> ?p ?o ?g. }

• W3083232014 endingPage "434" @default.
• W3083232014 startingPage "421" @default.
• W3083232014 abstract "The optimal agent to treat acute agitation in the emergency department (ED) has not been determined. The objective of this study was to compare the effectiveness and safety of intramuscular droperidol, ziprasidone, and lorazepam for acute agitation in the ED.This was a randomized, double-blind trial of ED patients with acute agitation requiring parenteral sedation. The study was conducted under exception from informed consent (21 CFR 50.24) from July 2004 to March 2005. Patients were randomized to receive 5 mg of droperidol, 10 mg of ziprasidone, 20 mg of ziprasidone, or 2 mg of lorazepam intramuscularly. We recorded Altered Mental Status Scale (AMSS) scores, nasal end-tidal carbon dioxide (ETCO2 ), and pulse oximetry (SpO2 ) at 0, 15, 30, 45, 60, 90, and 120 minutes as well as QTc durations and dysrhythmias. Respiratory depression was defined as a change in ETCO2 consistent with respiratory depression or SpO2 < 90%. The primary outcome was the proportion of patients adequately sedated (AMSS ≤ 0) at 15 minutes.We enrolled 115 patients. Baseline AMSS scores were similar between groups. For the primary outcome, adequate sedation at 15 minutes, droperidol administration was effective in 16 of 25 (64%) patients, compared to seven of 28 (25%) for 10 mg of ziprasidone, 11 of 31 (35%) for 20 mg of ziprasidone, and nine of 31 (29%) for lorazepam. Pairwise comparisons revealed that droperidol was more effective that the other medications, with 39% (95% confidence interval [CI] = 3% to 54%) more compared to 20 mg of ziprasidone and 33% (95% CI = 8% to 58%) more compared to lorazepam. There was no significant difference between groups in need of additional rescue sedation. Numerically, respiratory depression was lower with droperidol (3/25 [12%]) compared to 10 mg of ziprasidone (10/28 [36%]), 20 mg of ziprasidone (12/31 [39%]), or lorazepam (15/31 [48%]). One patient receiving 20 mg of ziprasidone required intubation to manage an acute subdural hematoma. No patients had ventricular dysrhythmias. QTc durations were similar in all groups.Droperidol was more effective than lorazepam or either dose of ziprasidone for the treatment of acute agitation in the ED and caused fewer episodes of respiratory depression." @default.
• W3083232014 created "2020-09-11" @default.
• W3083232014 creator A5023310280 @default.
• W3083232014 creator A5049386972 @default.
• W3083232014 creator A5062320586 @default.
• W3083232014 creator A5075900301 @default.
• W3083232014 creator A5076389841 @default.
• W3083232014 date "2020-10-05" @default.
• W3083232014 modified "2023-10-10" @default.
• W3083232014 title "Randomized Double‐blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department" @default.
• W3083232014 cites W1605283120 @default.
• W3083232014 cites W1964320139 @default.
• W3083232014 cites W1964906438 @default.
• W3083232014 cites W1983625342 @default.
• W3083232014 cites W2016383988 @default.
• W3083232014 cites W2022657724 @default.
• W3083232014 cites W2022819467 @default.
• W3083232014 cites W2023774298 @default.
• W3083232014 cites W2040729986 @default.
• W3083232014 cites W2041614404 @default.
• W3083232014 cites W2057471261 @default.
• W3083232014 cites W2060455360 @default.
• W3083232014 cites W2062665760 @default.
• W3083232014 cites W2068544055 @default.
• W3083232014 cites W2073374123 @default.
• W3083232014 cites W2074041636 @default.
• W3083232014 cites W2080082687 @default.
• W3083232014 cites W2091599295 @default.
• W3083232014 cites W2133639146 @default.
• W3083232014 cites W2157127050 @default.
• W3083232014 cites W2161096839 @default.
• W3083232014 cites W2205962720 @default.
• W3083232014 cites W2288746277 @default.
• W3083232014 cites W2338150054 @default.
• W3083232014 cites W2508352494 @default.
• W3083232014 cites W2519094079 @default.
• W3083232014 cites W2531039051 @default.
• W3083232014 cites W2547539042 @default.
• W3083232014 cites W2560663136 @default.
• W3083232014 cites W2583859672 @default.
• W3083232014 cites W2613843351 @default.
• W3083232014 cites W2726198236 @default.
• W3083232014 cites W2735255872 @default.
• W3083232014 cites W2750014358 @default.
• W3083232014 cites W2764162749 @default.
• W3083232014 cites W2764334882 @default.
• W3083232014 cites W2774476615 @default.
• W3083232014 cites W2790579272 @default.
• W3083232014 cites W2801081612 @default.
• W3083232014 cites W2805599229 @default.
• W3083232014 cites W2807443001 @default.
• W3083232014 cites W2884344931 @default.
• W3083232014 cites W2884852222 @default.
• W3083232014 cites W2885279096 @default.
• W3083232014 cites W2889897811 @default.
• W3083232014 cites W2891349427 @default.
• W3083232014 cites W2896790421 @default.
• W3083232014 cites W2900774211 @default.
• W3083232014 cites W2904067182 @default.
• W3083232014 cites W2914738272 @default.
• W3083232014 cites W2953403218 @default.
• W3083232014 cites W2972622342 @default.
• W3083232014 cites W2990701345 @default.
• W3083232014 cites W3015718133 @default.
• W3083232014 cites W3044778632 @default.
• W3083232014 cites W4250507448 @default.
• W3083232014 cites W4295974821 @default.
• W3083232014 doi "https://doi.org/10.1111/acem.14124" @default.
• W3083232014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32888340" @default.
• W3083232014 hasPublicationYear "2020" @default.
• W3083232014 type Work @default.
• W3083232014 sameAs 3083232014 @default.
• W3083232014 citedByCount "16" @default.
• W3083232014 countsByYear W30832320142021 @default.
• W3083232014 countsByYear W30832320142022 @default.
• W3083232014 countsByYear W30832320142023 @default.
• W3083232014 crossrefType "journal-article" @default.
• W3083232014 hasAuthorship W3083232014A5023310280 @default.
• W3083232014 hasAuthorship W3083232014A5049386972 @default.
• W3083232014 hasAuthorship W3083232014A5062320586 @default.
• W3083232014 hasAuthorship W3083232014A5075900301 @default.
• W3083232014 hasAuthorship W3083232014A5076389841 @default.
• W3083232014 hasBestOaLocation W30832320141 @default.
• W3083232014 hasConcept C118552586 @default.
• W3083232014 hasConcept C141071460 @default.
• W3083232014 hasConcept C168563851 @default.
• W3083232014 hasConcept C2776153860 @default.
• W3083232014 hasConcept C2776412080 @default.
• W3083232014 hasConcept C2776619155 @default.
• W3083232014 hasConcept C2776814716 @default.
• W3083232014 hasConcept C2777270317 @default.
• W3083232014 hasConcept C2779425338 @default.
• W3083232014 hasConcept C2779706987 @default.
• W3083232014 hasConcept C2780724011 @default.
• W3083232014 hasConcept C2780852908 @default.
• W3083232014 hasConcept C42219234 @default.
• W3083232014 hasConcept C71924100 @default.
• W3083232014 hasConceptScore W3083232014C118552586 @default.

• next